Domain presents target identification strategy to identify novel immune checkpoint from GPCR-ome at the AACR 2020
Check out our virtual posters ! Available on our website and at the #AACR20 from June 22, 2020 at 9:00 AM EDT.
GPCR-ome modulation upon PD1/PDL1 axis blockade (Poster #934), co-authored with Explicyte, Bordeaux, France and Institut Bergonié, Bordeaux, France, discloses an in-depth GPCR expression analysis from tumor micro environment to dissect out mechanism of resistance to immune checkpoint inhibitors. Such data open avenues for the discovery of the next generation of immune checkpoints.
Share this article